Open-mkt buys · 90d
—
0 trades · 0 insiders
Open-mkt sales · 90d
$6.95M
12 trades · 2 insiders
Net · 90d
$-6.95M
Insiders on file
27
Daily buy vs sell · 90 days
■ Open-market buys (P) ■ Open-market sales (S) · daily dollar value by transaction date
Insiders
| Insider | Role | Trades | Bought | Sold | Last trade |
|---|---|---|---|---|---|
| Higgins Jack | Chief Scientific Officer | 29 | $0 | $921.8K | 2026-09-11 |
| Barchas Isaac | Director | 21 | $0 | $21.41M | 2026-08-12 |
| Horn Kinney | CHIEF BUSINESS OFFICER | 18 | $0 | $4.57M | 2026-08-04 |
| Tsai Philip | Chief Technology Officer | 7 | $506.5K | $0 | 2026-07-23 |
| Lechleider Robert | Chief Medical Officer | 15 | $149.8K | $2.34M | 2026-07-23 |
| Rosett Max | EVP, Operations & CFO | 18 | $0 | $2.75M | 2026-07-23 |
| Stoneman Sandra G. | General Counsel and CLO | 9 | $0 | $0 | 2026-07-23 |
| SIEGALL CLAY B | President and CEO | 16 | $7.26M | $0 | 2026-07-23 |
| Boylan James P | Director | 4 | $0 | $0 | 2026-06-10 |
| SWAIN SANDRA M | Director | 4 | $0 | $0 | 2026-06-10 |
| WAGENHEIM PHILIP | Director | 11 | $247.7K | $1.34M | 2026-06-10 |
| SCHAFER CAROL | Director | 4 | $0 | $0 | 2026-06-10 |
| BIENAIME JEAN JACQUES | Director | 17 | $641.2K | $203.8K | 2026-06-10 |
| Turner Bruce | Chief Strategy Officer | 2 | $250.0K | $0 | 2024-08-09 |
| Roberts Phil Noland | Chief Technology Officer | 1 | $0 | $0 | 2023-12-13 |
| RAPP MICHAEL | Director, 10% Owner | 18 | $3.33M | $0 | 2023-10-02 |
| PRENDERGAST FRANKLYN G | Director | 5 | $0 | $0 | 2023-10-02 |
| ROBINSON MATTHEW K | Chief Technology Officer | 2 | $0 | $0 | 2023-06-08 |
| Roche Corleen M. | Chief Financial Officer | 4 | $0 | $0 | 2023-06-08 |
| Giesing Dennis H | Chief Development Officer | 4 | $0 | $0 | 2023-06-08 |
| Lefenfeld Michael | Director | 12 | $86.1K | $0 | 2023-06-08 |
| Sarma Purnanand D | president and CEO | 4 | $193.3K | $0 | 2023-06-08 |
| BARON RICHARD A | Director | 6 | $0 | $0 | 2023-06-08 |
| LAMATTINA JOHN L | Director | 11 | $101.0K | $0 | 2023-06-08 |
| Widlitz Michael | Director | 4 | $0 | $0 | 2021-05-28 |
| MORRIS I WISTAR III | 10% Owner | 6 | $0 | $0 | 2020-10-06 |
| Fitzgerald Richard F | Chief Financial Officer | 2 | $0 | $0 | 2020-10-01 |
Trade history
| Insider | Role | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|---|
| Higgins Jack | Chief Scientific Officer | M Exercise deriv | 2026-09-11 | 2026-09-15 | 18,000 | — | $0 | 133,840 | SEC↗ |
| Higgins Jack | Chief Scientific Officer | M Exercise | 2026-09-11 | 2026-09-15 | 18,000 | $1.35 | $24.3K | 78,250 | SEC↗ |
| Higgins Jack | Chief Scientific Officer | S Sale | 2026-09-11 | 2026-09-15 | 13,200 | $25.32 | $334.2K | 65,050 | SEC↗ |
| Higgins Jack | Chief Scientific Officer | G Gift | 2026-09-11 | 2026-09-15 | 8,800 | — | $0 | 56,250 | SEC↗ |
| Higgins Jack | Chief Scientific Officer | M Exercise deriv | 2026-09-11 | 2026-09-15 | 18,000 | — | $0 | 133,840 | SEC↗ |
| Higgins Jack | Chief Scientific Officer | G Gift | 2026-09-11 | 2026-09-15 | 8,800 | — | $0 | 56,250 | SEC↗ |
| Higgins Jack | Chief Scientific Officer | S Sale | 2026-09-11 | 2026-09-15 | 13,200 | $25.32 | $334.2K | 65,050 | SEC↗ |
| Higgins Jack | Chief Scientific Officer | M Exercise | 2026-09-11 | 2026-09-15 | 18,000 | $1.35 | $24.3K | 78,250 | SEC↗ |
| Barchas Isaac | Director | S Sale | 2026-08-12 | 2026-08-12 | 11,048 | $27.25 | $301.1K | 92,211 | SEC↗ |
| Barchas Isaac | Director | S Sale | 2026-08-12 | 2026-08-12 | 11,048 | $27.25 | $301.1K | 92,211 | SEC↗ |
| Barchas Isaac | Director | S Sale | 2026-08-11 | 2026-08-12 | 62,291 | $26.23 | $1.63M | 0 | SEC↗ |
| Barchas Isaac | Director | S Sale | 2026-08-11 | 2026-08-12 | 62,291 | $26.23 | $1.63M | 0 | SEC↗ |
| Barchas Isaac | Director | S Sale | 2026-08-10 | 2026-08-12 | 10,125 | $26.07 | $264.0K | 62,291 | SEC↗ |
| Barchas Isaac | Director | S Sale | 2026-08-10 | 2026-08-12 | 10,125 | $26.07 | $264.0K | 62,291 | SEC↗ |
| Barchas Isaac | Director | S Sale | 2026-08-07 | 2026-08-10 | 15,248 | $26.06 | $397.4K | 72,416 | SEC↗ |
| Barchas Isaac | Director | S Sale | 2026-08-07 | 2026-08-10 | 15,248 | $26.06 | $397.4K | 72,416 | SEC↗ |
| Barchas Isaac | Director | S Sale | 2026-08-06 | 2026-08-10 | 20,840 | $26.06 | $543.1K | 87,664 | SEC↗ |
| Barchas Isaac | Director | S Sale | 2026-08-06 | 2026-08-10 | 20,840 | $26.06 | $543.1K | 87,664 | SEC↗ |
| Horn Kinney | CHIEF BUSINESS OFFICER | M Exercise deriv | 2026-08-04 | 2026-08-06 | 40,250 | — | $0 | 120,750 | SEC↗ |
| Horn Kinney | CHIEF BUSINESS OFFICER | M Exercise deriv | 2026-08-04 | 2026-08-06 | 50,366 | — | $0 | 78,542 | SEC↗ |
| Horn Kinney | CHIEF BUSINESS OFFICER | S Sale | 2026-08-04 | 2026-08-06 | 90,616 | $25.09 | $2.27M | 0 | SEC↗ |
| Horn Kinney | CHIEF BUSINESS OFFICER | M Exercise | 2026-08-04 | 2026-08-06 | 50,366 | $12.92 | $650.7K | 50,366 | SEC↗ |
| Horn Kinney | CHIEF BUSINESS OFFICER | M Exercise | 2026-08-04 | 2026-08-06 | 40,250 | $10.60 | $426.6K | 90,616 | SEC↗ |
| Horn Kinney | CHIEF BUSINESS OFFICER | M Exercise deriv | 2026-08-04 | 2026-08-06 | 40,250 | — | $0 | 120,750 | SEC↗ |
| Horn Kinney | CHIEF BUSINESS OFFICER | M Exercise deriv | 2026-08-04 | 2026-08-06 | 50,366 | — | $0 | 78,542 | SEC↗ |
| Horn Kinney | CHIEF BUSINESS OFFICER | S Sale | 2026-08-04 | 2026-08-06 | 90,616 | $25.09 | $2.27M | 0 | SEC↗ |
| Horn Kinney | CHIEF BUSINESS OFFICER | M Exercise | 2026-08-04 | 2026-08-06 | 40,250 | $10.60 | $426.6K | 90,616 | SEC↗ |
| Horn Kinney | CHIEF BUSINESS OFFICER | M Exercise | 2026-08-04 | 2026-08-06 | 50,366 | $12.92 | $650.7K | 50,366 | SEC↗ |
| SIEGALL CLAY B | President and CEO | A Award deriv | 2026-07-23 | 2026-07-27 | 360,000 | — | $0 | 360,000 | SEC↗ |
| Lechleider Robert | Chief Medical Officer | A Award deriv | 2026-07-23 | 2026-07-27 | 108,000 | — | $0 | 108,000 | SEC↗ |
| Rosett Max | Chief Financial Officer | A Award deriv | 2026-07-23 | 2026-07-27 | 94,500 | — | $0 | 94,500 | SEC↗ |
| Higgins Jack | Chief Scientific Officer | A Award deriv | 2026-07-23 | 2026-07-27 | 76,500 | — | $0 | 76,500 | SEC↗ |
| Stoneman Sandra G. | CHIEF LEGAL OFFICER & GC | A Award deriv | 2026-07-23 | 2026-07-27 | 76,500 | — | $0 | 76,500 | SEC↗ |
| Tsai Philip | Chief Technical Officer | A Award deriv | 2026-07-23 | 2026-07-27 | 76,500 | — | $0 | 76,500 | SEC↗ |
| Horn Kinney | CHIEF BUSINESS OFFICER | A Award deriv | 2026-07-23 | 2026-07-27 | 62,500 | — | $0 | 62,500 | SEC↗ |
| SIEGALL CLAY B | President and CEO | A Award | 2026-07-23 | 2026-07-27 | 180,000 | — | $0 | 870,704 | SEC↗ |
| Lechleider Robert | Chief Medical Officer | A Award | 2026-07-23 | 2026-07-27 | 54,000 | — | $0 | 69,805 | SEC↗ |
| Rosett Max | Chief Financial Officer | A Award | 2026-07-23 | 2026-07-27 | 47,250 | — | $0 | 101,287 | SEC↗ |
| Higgins Jack | Chief Scientific Officer | A Award | 2026-07-23 | 2026-07-27 | 38,250 | — | $0 | 60,250 | SEC↗ |
| Stoneman Sandra G. | CHIEF LEGAL OFFICER & GC | A Award | 2026-07-23 | 2026-07-27 | 38,250 | — | $0 | 43,805 | SEC↗ |
| Tsai Philip | Chief Technical Officer | A Award | 2026-07-23 | 2026-07-27 | 38,250 | — | $0 | 81,550 | SEC↗ |
| Horn Kinney | CHIEF BUSINESS OFFICER | A Award | 2026-07-23 | 2026-07-27 | 31,250 | — | $0 | 31,250 | SEC↗ |
| Horn Kinney | CHIEF BUSINESS OFFICER | M Exercise deriv | 2026-07-07 | 2026-07-09 | 1,092 | — | $0 | 128,908 | SEC↗ |
| Barchas Isaac | Director | S Sale | 2026-07-07 | 2026-07-07 | 16,906 | $24.20 | $409.1K | 108,504 | SEC↗ |
| Horn Kinney | CHIEF BUSINESS OFFICER | S Sale | 2026-07-07 | 2026-07-09 | 1,092 | $25.00 | $27.3K | 0 | SEC↗ |
| Horn Kinney | CHIEF BUSINESS OFFICER | M Exercise | 2026-07-07 | 2026-07-09 | 1,092 | $12.92 | $14.1K | 1,092 | SEC↗ |
| Barchas Isaac | Director | S Sale | 2026-07-06 | 2026-07-07 | 83,094 | $24.11 | $2.00M | 125,410 | SEC↗ |
| Lechleider Robert | Chief Medical Officer | M Exercise deriv | 2026-07-02 | 2026-07-07 | 55,000 | — | $0 | 290,000 | SEC↗ |
| Barchas Isaac | Director | S Sale | 2026-07-02 | 2026-07-02 | 24,335 | $23.33 | $567.7K | 208,504 | SEC↗ |
| Barchas Isaac | Director | S Sale | 2026-07-02 | 2026-07-02 | 75,665 | $22.35 | $1.69M | 232,839 | SEC↗ |
| Lechleider Robert | Chief Medical Officer | S Sale | 2026-07-02 | 2026-07-07 | 22,714 | $21.95 | $498.6K | 48,091 | SEC↗ |
| Lechleider Robert | Chief Medical Officer | S Sale | 2026-07-02 | 2026-07-07 | 16,214 | $22.76 | $369.0K | 31,877 | SEC↗ |
| Lechleider Robert | Chief Medical Officer | S Sale | 2026-07-02 | 2026-07-07 | 16,072 | $23.44 | $376.7K | 15,805 | SEC↗ |
| Lechleider Robert | Chief Medical Officer | M Exercise | 2026-07-02 | 2026-07-07 | 55,000 | $8.73 | $480.1K | 70,805 | SEC↗ |
| Barchas Isaac | Director | S Sale | 2026-06-30 | 2026-07-02 | 101,050 | $21.12 | $2.13M | 308,504 | SEC↗ |
| Lechleider Robert | Chief Medical Officer | M Exercise deriv | 2026-06-25 | 2026-06-29 | 55,000 | — | $0 | 345,000 | SEC↗ |
| Lechleider Robert | Chief Medical Officer | S Sale | 2026-06-25 | 2026-06-29 | 14,420 | $20.66 | $297.9K | 15,805 | SEC↗ |
| Lechleider Robert | Chief Medical Officer | M Exercise | 2026-06-25 | 2026-06-29 | 55,000 | $8.73 | $480.1K | 70,805 | SEC↗ |
| Lechleider Robert | Chief Medical Officer | S Sale | 2026-06-25 | 2026-06-29 | 40,580 | $19.56 | $793.7K | 30,225 | SEC↗ |
| Rosett Max | Chief Financial Officer | M Exercise deriv | 2026-06-15 | 2026-06-17 | 60,000 | — | $0 | 0 | SEC↗ |
| Rosett Max | Chief Financial Officer | M Exercise | 2026-06-15 | 2026-06-17 | 60,000 | $1.05 | $63.0K | 114,037 | SEC↗ |
| Rosett Max | Chief Financial Officer | S Sale | 2026-06-15 | 2026-06-17 | 60,000 | $18.23 | $1.09M | 54,037 | SEC↗ |
| SCHAFER CAROL | Director | A Award deriv | 2026-06-10 | 2026-06-12 | 9,897 | — | $0 | 9,897 | SEC↗ |
| Barchas Isaac | Director | A Award deriv | 2026-06-10 | 2026-06-12 | 9,897 | — | $0 | 9,897 | SEC↗ |
| Boylan James P | Director | A Award deriv | 2026-06-10 | 2026-06-12 | 9,897 | — | $0 | 9,897 | SEC↗ |
| BIENAIME JEAN JACQUES | Director | A Award deriv | 2026-06-10 | 2026-06-12 | 9,897 | — | $0 | 9,897 | SEC↗ |
| WAGENHEIM PHILIP | Director | A Award deriv | 2026-06-10 | 2026-06-12 | 9,897 | — | $0 | 9,897 | SEC↗ |
| SWAIN SANDRA M | Director | A Award deriv | 2026-06-10 | 2026-06-12 | 9,897 | — | $0 | 9,897 | SEC↗ |
| BIENAIME JEAN JACQUES | Director | P Buy | 2026-06-05 | 2026-06-09 | 1,000 | $19.27 | $19.3K | 43,415 | SEC↗ |
| BIENAIME JEAN JACQUES | Director | P Buy | 2026-06-05 | 2026-06-09 | 3,500 | $19.46 | $68.1K | 42,415 | SEC↗ |
| BIENAIME JEAN JACQUES | Director | P Buy | 2026-06-05 | 2026-06-09 | 6,000 | $19.48 | $116.9K | 38,915 | SEC↗ |
| BIENAIME JEAN JACQUES | Director | S Sale | 2026-06-05 | 2026-06-09 | 10,000 | $19.41 | $194.1K | 32,915 | SEC↗ |
| BIENAIME JEAN JACQUES | Director | S Sale | 2026-06-05 | 2026-06-09 | 500 | $19.44 | $9.7K | 42,915 | SEC↗ |
| BIENAIME JEAN JACQUES | Director | P Buy | 2026-05-15 | 2026-05-19 | 5,000 | $20.70 | $103.5K | 43,415 | SEC↗ |
| Rosett Max | Chief Financial Officer | M Exercise deriv | 2026-04-02 | 2026-04-03 | 39,713 | — | $0 | 0 | SEC↗ |
| Rosett Max | Chief Financial Officer | M Exercise deriv | 2026-04-02 | 2026-04-03 | 31,848 | — | $0 | 60,000 | SEC↗ |
| Rosett Max | Chief Financial Officer | M Exercise | 2026-04-02 | 2026-04-03 | 31,848 | $1.05 | $33.4K | 79,324 | SEC↗ |
| Rosett Max | Chief Financial Officer | M Exercise | 2026-04-02 | 2026-04-03 | 39,713 | $1.35 | $53.6K | 119,037 | SEC↗ |
| Rosett Max | Chief Financial Officer | S Sale | 2026-04-02 | 2026-04-03 | 63,656 | $21.91 | $1.39M | 55,381 | SEC↗ |
| Rosett Max | Chief Financial Officer | S Sale | 2026-04-02 | 2026-04-03 | 1,344 | $22.48 | $30.2K | 54,037 | SEC↗ |
| Higgins Jack | Chief Scientific Officer | S Sale | 2026-04-02 | 2026-04-03 | 9,438 | $21.64 | $204.2K | 22,000 | SEC↗ |
| Higgins Jack | Chief Scientific Officer | G Gift | 2026-03-30 | 2026-04-01 | 6,291 | — | $0 | 31,438 | SEC↗ |
| SIEGALL CLAY B | President and CEO | P Buy | 2026-03-27 | 2026-03-31 | 25,450 | $19.67 | $500.6K | 690,704 | SEC↗ |
| WAGENHEIM PHILIP | Director | S Sale | 2026-03-23 | 2026-03-23 | 28,200 | $20.65 | $582.3K | 341,147 | SEC↗ |
| WAGENHEIM PHILIP | Director | S Sale | 2026-03-20 | 2026-03-23 | 36,800 | $20.47 | $753.3K | 369,347 | SEC↗ |
| BIENAIME JEAN JACQUES | Director | P Buy | 2026-03-11 | 2026-03-12 | 1,000 | $21.55 | $21.6K | 38,415 | SEC↗ |
| BIENAIME JEAN JACQUES | Director | P Buy | 2026-03-10 | 2026-03-12 | 1,000 | $22.12 | $22.1K | 37,415 | SEC↗ |
| SIEGALL CLAY B | President and CEO | P Buy | 2025-12-30 | 2025-12-30 | 4,729 | $21.15 | $100.0K | 665,254 | SEC↗ |
| Barchas Isaac | Director | S Sale | 2025-12-22 | 2025-12-23 | 11,251 | $22.34 | $251.3K | 2,031,181 | SEC↗ |
| Barchas Isaac | Director | S Sale | 2025-12-22 | 2025-12-23 | 371,949 | $21.72 | $8.08M | 2,042,432 | SEC↗ |
| Tsai Philip | Chief Technical Officer | P Buy | 2025-12-19 | 2025-12-22 | 10,000 | $20.49 | $204.9K | 43,300 | SEC↗ |
| SIEGALL CLAY B | President and CEO | P Buy | 2025-12-19 | 2025-12-22 | 7,278 | $20.48 | $149.1K | 860,525 | SEC↗ |
| SIEGALL CLAY B | President and CEO | G Gift | 2025-12-19 | 2025-12-22 | 200,000 | — | $0 | 660,525 | SEC↗ |
| Higgins Jack | Chief Scientific Officer | G Gift | 2025-12-19 | 2025-12-22 | 1,000 | — | $0 | 1,000 | SEC↗ |
| Higgins Jack | Chief Scientific Officer | G Gift | 2025-12-19 | 2025-12-22 | 1,000 | — | $0 | 38,729 | SEC↗ |
| Higgins Jack | Chief Scientific Officer | G Gift | 2025-12-19 | 2025-12-22 | 1,000 | — | $0 | 39,729 | SEC↗ |
| Higgins Jack | Chief Scientific Officer | G Gift | 2025-12-19 | 2025-12-22 | 1,000 | — | $0 | 37,729 | SEC↗ |
| Higgins Jack | Chief Scientific Officer | G Gift | 2025-12-19 | 2025-12-22 | 1,000 | — | $0 | 1,000 | SEC↗ |
| Higgins Jack | Chief Scientific Officer | G Gift | 2025-12-19 | 2025-12-22 | 1,000 | — | $0 | 1,000 | SEC↗ |
| SIEGALL CLAY B | President and CEO | P Buy | 2025-12-18 | 2025-12-18 | 46,511 | $21.50 | $1000.0K | 853,247 | SEC↗ |
| Higgins Jack | Chief Scientific Officer | M Exercise deriv | 2025-09-10 | 2025-09-11 | 22,000 | — | $0 | 151,840 | SEC↗ |
| Higgins Jack | Chief Scientific Officer | M Exercise | 2025-09-10 | 2025-09-11 | 22,000 | $1.35 | $29.7K | 40,729 | SEC↗ |
| Stoneman Sandra G. | CHIEF LEGAL OFFICER & GC | A Award deriv | 2025-07-29 | 2025-07-31 | 190,000 | — | $0 | 190,000 | SEC↗ |
| SIEGALL CLAY B | President and CEO | A Award deriv | 2025-07-29 | 2025-07-31 | 800,000 | — | $0 | 800,000 | SEC↗ |
| Higgins Jack | Chief Scientific Officer | A Award deriv | 2025-07-29 | 2025-07-31 | 196,000 | — | $0 | 196,000 | SEC↗ |
| Horn Kinney | CHIEF BUSINESS OFFICER | A Award deriv | 2025-07-29 | 2025-07-31 | 161,000 | — | $0 | 161,000 | SEC↗ |
| Lechleider Robert | Chief Medical Officer | A Award deriv | 2025-07-29 | 2025-07-31 | 242,000 | — | $0 | 242,000 | SEC↗ |
| Rosett Max | Chief Financial Officer | A Award deriv | 2025-07-29 | 2025-07-31 | 207,000 | — | $0 | 207,000 | SEC↗ |
| Tsai Philip | Chief Technical Officer | A Award deriv | 2025-07-29 | 2025-07-31 | 190,000 | — | $0 | 190,000 | SEC↗ |
| SWAIN SANDRA M | Director | A Award deriv | 2025-06-10 | 2025-06-12 | 18,864 | — | $0 | 18,864 | SEC↗ |
| BIENAIME JEAN JACQUES | Director | A Award deriv | 2025-06-10 | 2025-06-12 | 18,864 | — | $0 | 18,864 | SEC↗ |
| Barchas Isaac | Director | A Award deriv | 2025-06-10 | 2025-06-12 | 18,864 | — | $0 | 18,864 | SEC↗ |
| WAGENHEIM PHILIP | Director | A Award deriv | 2025-06-10 | 2025-06-12 | 18,864 | — | $0 | 18,864 | SEC↗ |
| SCHAFER CAROL | Director | A Award deriv | 2025-06-10 | 2025-06-12 | 18,864 | — | $0 | 18,864 | SEC↗ |
| Boylan James P | Director | A Award deriv | 2025-06-10 | 2025-06-12 | 18,864 | — | $0 | 18,864 | SEC↗ |
| BIENAIME JEAN JACQUES | Director | P Buy | 2025-06-03 | 2025-06-03 | 5,000 | $9.38 | $46.9K | 36,415 | SEC↗ |
| Higgins Jack | Chief Scientific Officer | M Exercise deriv | 2025-03-27 | 2025-03-28 | 5,200 | — | $0 | 173,840 | SEC↗ |
| Higgins Jack | Chief Scientific Officer | M Exercise | 2025-03-27 | 2025-03-28 | 5,200 | $1.35 | $7.0K | 18,729 | SEC↗ |
| SIEGALL CLAY B | President and CEO | P Buy | 2025-03-26 | 2025-03-26 | 137,100 | $7.29 | $999.5K | 806,736 | SEC↗ |
| BIENAIME JEAN JACQUES | Director | P Buy | 2025-03-25 | 2025-03-26 | 7,800 | $7.78 | $60.7K | 31,415 | SEC↗ |
| Tsai Philip | Chief Technology Officer | P Buy | 2025-03-24 | 2025-03-25 | 12,300 | $8.42 | $103.6K | 33,300 | SEC↗ |
| BIENAIME JEAN JACQUES | Director | P Buy | 2025-03-24 | 2025-03-25 | 7,000 | $8.21 | $57.5K | 23,615 | SEC↗ |
| SIEGALL CLAY B | President and CEO | P Buy | 2025-01-31 | 2025-02-03 | 150,000 | $7.75 | $1.16M | 669,636 | SEC↗ |
| SIEGALL CLAY B | President and CEO | P Buy | 2024-11-22 | 2024-11-25 | 33,943 | $9.78 | $332.0K | 519,636 | SEC↗ |
| Tsai Philip | Chief Technology Officer | P Buy | 2024-11-21 | 2024-11-25 | 21,000 | $9.43 | $198.0K | 21,000 | SEC↗ |
| Lechleider Robert | Chief Medical Officer | P Buy | 2024-11-21 | 2024-11-25 | 15,805 | $9.48 | $149.8K | 15,805 | SEC↗ |
| SIEGALL CLAY B | President and CEO | P Buy | 2024-11-21 | 2024-11-25 | 66,057 | $9.54 | $630.2K | 485,693 | SEC↗ |
| Rosett Max | Chief Financial Officer | M Exercise deriv | 2024-09-19 | 2024-09-20 | 42,000 | — | $0 | 91,848 | SEC↗ |
| Rosett Max | Chief Financial Officer | M Exercise | 2024-09-19 | 2024-09-20 | 42,000 | $1.05 | $44.1K | 61,856 | SEC↗ |
| Rosett Max | Chief Financial Officer | S Sale | 2024-09-19 | 2024-09-20 | 14,380 | $16.01 | $230.2K | 47,476 | SEC↗ |
| Higgins Jack | Chief Scientific Officer | G Gift | 2024-08-19 | 2024-08-19 | 2,471 | — | $0 | 13,529 | SEC↗ |
| BIENAIME JEAN JACQUES | Director | P Buy | 2024-08-16 | 2024-08-19 | 7,000 | $13.94 | $97.6K | 16,615 | SEC↗ |
| Higgins Jack | Chief Scientific Officer | M Exercise deriv | 2024-08-15 | 2024-08-19 | 19,524 | — | $0 | 179,040 | SEC↗ |
| Higgins Jack | Chief Scientific Officer | M Exercise | 2024-08-15 | 2024-08-19 | 19,524 | $1.35 | $26.4K | 19,524 | SEC↗ |
| Higgins Jack | Chief Scientific Officer | S Sale | 2024-08-15 | 2024-08-19 | 3,524 | $13.93 | $49.1K | 16,000 | SEC↗ |
| Higgins Jack | Chief Scientific Officer | A Award deriv | 2024-08-09 | 2024-08-13 | 190,000 | — | $0 | 190,000 | SEC↗ |
| Lechleider Robert | Chief Medical Officer | A Award deriv | 2024-08-09 | 2024-08-13 | 200,000 | — | $0 | 200,000 | SEC↗ |
| Rosett Max | EVP, Operations & CFO | A Award deriv | 2024-08-09 | 2024-08-13 | 190,000 | — | $0 | 190,000 | SEC↗ |
| Turner Bruce | Chief Strategy Officer | A Award deriv | 2024-08-09 | 2024-08-13 | 110,000 | — | $0 | 110,000 | SEC↗ |
| Horn Kinney | CHIEF BUSINESS OFFICER | A Award deriv | 2024-08-09 | 2024-08-13 | 130,000 | — | $0 | 130,000 | SEC↗ |
| Stoneman Sandra G. | CHIEF LEGAL OFFICER & GC | A Award deriv | 2024-08-09 | 2024-08-13 | 210,000 | — | $0 | 210,000 | SEC↗ |
| SIEGALL CLAY B | President and CEO | A Award deriv | 2024-08-09 | 2024-08-13 | 800,000 | — | $0 | 800,000 | SEC↗ |
| Tsai Philip | Chief Technology Officer | A Award deriv | 2024-06-17 | 2024-06-18 | 250,000 | — | $0 | 250,000 | SEC↗ |
| Barchas Isaac | Director | A Award deriv | 2024-06-13 | 2024-06-18 | 11,333 | — | $0 | 11,333 | SEC↗ |
| BIENAIME JEAN JACQUES | Director | A Award deriv | 2024-06-13 | 2024-06-18 | 11,333 | — | $0 | 11,333 | SEC↗ |
| WAGENHEIM PHILIP | Director | A Award deriv | 2024-06-13 | 2024-06-18 | 11,333 | — | $0 | 11,333 | SEC↗ |
| SWAIN SANDRA M | Director | A Award deriv | 2024-06-13 | 2024-06-18 | 11,333 | — | $0 | 11,333 | SEC↗ |
| SCHAFER CAROL | Director | A Award deriv | 2024-06-13 | 2024-06-18 | 11,333 | — | $0 | 11,333 | SEC↗ |
| Boylan James P | Director | A Award deriv | 2024-06-13 | 2024-06-18 | 11,333 | — | $0 | 11,333 | SEC↗ |
| SIEGALL CLAY B | President and CEO | P Buy | 2024-05-21 | 2024-05-21 | 20,434 | $13.78 | $281.6K | 419,636 | SEC↗ |
| BIENAIME JEAN JACQUES | Director | P Buy | 2024-05-21 | 2024-05-22 | 2,000 | $13.57 | $27.1K | 9,615 | SEC↗ |
| SIEGALL CLAY B | President and CEO | P Buy | 2024-05-20 | 2024-05-21 | 79,566 | $13.91 | $1.11M | 399,202 | SEC↗ |
| Rosett Max | EVP, Operations & CFO | A Award deriv | 2024-05-16 | 2024-05-17 | 30,000 | — | $0 | 30,000 | SEC↗ |
| SWAIN SANDRA M | Director | A Award deriv | 2024-04-25 | 2024-04-29 | 25,737 | — | $0 | 25,737 | SEC↗ |
| Horn Kinney | CHIEF BUSINESS OFFICER | A Award deriv | 2024-02-20 | 2024-02-21 | 300,000 | — | $0 | 300,000 | SEC↗ |
| Stoneman Sandra G. | CHIEF LEGAL OFFICER & GC | A Award deriv | 2024-01-31 | 2024-01-31 | 200,000 | — | $0 | 200,000 | SEC↗ |
| Rosett Max | EVP, OPERATIONS & INTERIM CF | A Award deriv | 2024-01-31 | 2024-01-31 | 175,000 | — | $0 | 175,000 | SEC↗ |
| SCHAFER CAROL | Director | A Award deriv | 2024-01-02 | 2024-01-04 | 32,934 | — | $0 | 32,934 | SEC↗ |
| Roberts Phil Noland | Chief Technology Officer | A Award deriv | 2023-12-13 | 2023-12-15 | 275,000 | — | $0 | 275,000 | SEC↗ |
| Higgins Jack | Chief Scientific Officer | A Award deriv | 2023-12-01 | 2023-12-05 | 200,000 | — | $0 | 200,000 | SEC↗ |
| BIENAIME JEAN JACQUES | Director | A Award deriv | 2023-11-07 | 2023-11-09 | 40,696 | — | $0 | 40,696 | SEC↗ |
| Lechleider Robert | Chief Medical Officer | A Award deriv | 2023-10-27 | 2023-10-31 | 400,000 | — | $0 | 400,000 | SEC↗ |
| Boylan James P | Director | A Award deriv | 2023-10-27 | 2023-10-31 | 41,538 | — | $0 | 41,538 | SEC↗ |
| Barchas Isaac | Director | A Award deriv | 2023-10-27 | 2023-10-31 | 41,538 | — | $0 | 41,538 | SEC↗ |
| PRENDERGAST FRANKLYN G | Director | A Award deriv | 2023-10-02 | 2023-10-04 | 137,725 | $1.35 | $185.9K | 137,725 | SEC↗ |
| RAPP MICHAEL | Director | A Award | 2023-10-02 | 2023-10-03 | 253,806 | $5.91 | $1.50M | 1,071,172 | SEC↗ |
| PRENDERGAST FRANKLYN G | Director | A Award | 2023-10-02 | 2023-10-04 | 60,840 | — | $0 | 60,840 | SEC↗ |
| Turner Bruce | Chief Strategy Officer | P Buy | 2023-10-02 | 2023-10-04 | 42,300 | $5.91 | $250.0K | 42,300 | SEC↗ |
| SIEGALL CLAY B | President and CEO | P Buy | 2023-10-02 | 2023-10-04 | 169,204 | $5.91 | $1000.0K | 319,636 | SEC↗ |
| Giesing Dennis H | Chief Development Officer | A Award deriv | 2023-06-08 | 2023-06-12 | 50,000 | — | $0 | 50,000 | SEC↗ |
| WAGENHEIM PHILIP | Director | A Award deriv | 2023-06-08 | 2023-06-12 | 6,500 | — | $0 | 6,500 | SEC↗ |
| PRENDERGAST FRANKLYN G | Director | A Award deriv | 2023-06-08 | 2023-06-12 | 6,500 | — | $0 | 6,500 | SEC↗ |
| BARON RICHARD A | Director | A Award deriv | 2023-06-08 | 2023-06-12 | 6,500 | — | $0 | 6,500 | SEC↗ |
| LAMATTINA JOHN L | Director | A Award deriv | 2023-06-08 | 2023-06-12 | 6,500 | — | $0 | 6,500 | SEC↗ |
| Lefenfeld Michael | Director | A Award deriv | 2023-06-08 | 2023-06-12 | 6,500 | — | $0 | 6,500 | SEC↗ |
| Sarma Purnanand D | President and CEO | A Award deriv | 2023-06-08 | 2023-06-12 | 166,500 | — | $0 | 166,500 | SEC↗ |
| ROBINSON MATTHEW K | Chief Technology Officer | A Award deriv | 2023-06-08 | 2023-06-12 | 58,000 | — | $0 | 58,000 | SEC↗ |
| Roche Corleen M. | Chief Financial Officer | A Award deriv | 2023-06-08 | 2023-06-12 | 58,000 | — | $0 | 58,000 | SEC↗ |
| Stoneman Sandra G. | General Counsel and CLO | A Award deriv | 2023-06-08 | 2023-06-12 | 56,000 | — | $0 | 56,000 | SEC↗ |
| RAPP MICHAEL | Director | A Award deriv | 2023-06-08 | 2023-06-12 | 6,500 | — | $0 | 6,500 | SEC↗ |
| RAPP MICHAEL | Director | A Award | 2023-01-15 | 2023-01-17 | 17,500 | $4.00 | $70.0K | 817,366 | SEC↗ |
| Lefenfeld Michael | Director | A Award | 2023-01-15 | 2023-01-17 | 13,875 | $4.00 | $55.5K | 40,747 | SEC↗ |
| LAMATTINA JOHN L | Director | A Award | 2023-01-15 | 2023-01-17 | 15,125 | $4.00 | $60.5K | 66,953 | SEC↗ |
| WAGENHEIM PHILIP | Director | A Award | 2023-01-15 | 2023-01-17 | 8,750 | $4.00 | $35.0K | 406,147 | SEC↗ |
| BARON RICHARD A | Director | A Award deriv | 2022-06-16 | 2022-06-21 | 6,500 | — | $0 | 6,500 | SEC↗ |
| LAMATTINA JOHN L | Director | A Award deriv | 2022-06-16 | 2022-06-21 | 6,500 | — | $0 | 6,500 | SEC↗ |
| Lefenfeld Michael | Director | A Award deriv | 2022-06-16 | 2022-06-21 | 6,500 | — | $0 | 6,500 | SEC↗ |
| PRENDERGAST FRANKLYN G | Director | A Award deriv | 2022-06-16 | 2022-06-21 | 6,500 | — | $0 | 6,500 | SEC↗ |
| RAPP MICHAEL | Director | A Award deriv | 2022-06-16 | 2022-06-21 | 6,500 | — | $0 | 6,500 | SEC↗ |
| WAGENHEIM PHILIP | Director | A Award deriv | 2022-06-16 | 2022-06-21 | 6,500 | — | $0 | 6,500 | SEC↗ |
| Giesing Dennis H | Chief Development Officer | A Award deriv | 2022-06-16 | 2022-06-21 | 60,000 | — | $0 | 60,000 | SEC↗ |
| ROBINSON MATTHEW K | Chief Technology Officer | A Award deriv | 2022-06-16 | 2022-06-21 | 35,000 | — | $0 | 35,000 | SEC↗ |
| Roche Corleen M. | Chief Financial Officer | A Award deriv | 2022-06-16 | 2022-06-21 | 70,000 | — | $0 | 70,000 | SEC↗ |
| Sarma Purnanand D | President and CEO | A Award deriv | 2022-06-16 | 2022-06-21 | 121,000 | — | $0 | 121,000 | SEC↗ |
| Stoneman Sandra G. | General Counsel and CLO | A Award deriv | 2022-06-16 | 2022-06-21 | 43,000 | — | $0 | 43,000 | SEC↗ |
| RAPP MICHAEL | Director | P Buy | 2021-09-13 | 2021-09-14 | 25,962 | $19.96 | $518.2K | 208,742 | SEC↗ |
| RAPP MICHAEL | Director | P Buy | 2021-09-10 | 2021-09-13 | 15,500 | $17.85 | $276.7K | 182,780 | SEC↗ |
| RAPP MICHAEL | Director | P Buy | 2021-09-09 | 2021-09-13 | 8,170 | $17.44 | $142.5K | 145,000 | SEC↗ |
| RAPP MICHAEL | Director | P Buy | 2021-09-09 | 2021-09-13 | 22,280 | $18.46 | $411.3K | 167,280 | SEC↗ |
| BARON RICHARD A | Director | M Exercise deriv | 2021-08-18 | 2021-08-20 | 2,343 | — | $0 | 5,157 | SEC↗ |
| BARON RICHARD A | Director | M Exercise | 2021-08-18 | 2021-08-20 | 2,343 | $11.38 | $26.7K | 2,343 | SEC↗ |
| PRENDERGAST FRANKLYN G | Director | A Award deriv | 2021-06-16 | 2021-06-21 | 7,500 | — | $0 | 7,500 | SEC↗ |
| Sarma Purnanand D | president and CEO | A Award deriv | 2021-05-28 | 2021-06-01 | 93,354 | — | $0 | 93,354 | SEC↗ |
| Giesing Dennis H | Chief Development Officer | A Award deriv | 2021-05-28 | 2021-06-01 | 16,609 | — | $0 | 16,609 | SEC↗ |
| Stoneman Sandra G. | General Counsel and CLO | A Award deriv | 2021-05-28 | 2021-06-01 | 16,609 | — | $0 | 16,609 | SEC↗ |
| Roche Corleen M. | Chief Financial Officer | A Award deriv | 2021-05-28 | 2021-06-01 | 16,609 | — | $0 | 16,609 | SEC↗ |
| Widlitz Michael | Director | A Award deriv | 2021-05-28 | 2021-06-01 | 3,750 | — | $0 | 3,750 | SEC↗ |
| BARON RICHARD A | Director | A Award deriv | 2021-05-28 | 2021-06-01 | 3,750 | — | $0 | 3,750 | SEC↗ |
| LAMATTINA JOHN L | Director | A Award deriv | 2021-05-28 | 2021-06-01 | 3,750 | — | $0 | 3,750 | SEC↗ |
| RAPP MICHAEL | Director | A Award deriv | 2021-05-28 | 2021-06-01 | 3,750 | — | $0 | 3,750 | SEC↗ |
| Lefenfeld Michael | Director | A Award deriv | 2021-05-28 | 2021-06-01 | 3,750 | — | $0 | 3,750 | SEC↗ |
| WAGENHEIM PHILIP | Director | A Award deriv | 2021-05-28 | 2021-06-01 | 3,750 | — | $0 | 3,750 | SEC↗ |
| RAPP MICHAEL | Director | P Buy | 2021-05-26 | 2021-05-26 | 2,300 | $18.94 | $43.6K | 136,830 | SEC↗ |
| Lefenfeld Michael | Director | P Buy | 2021-05-26 | 2021-05-26 | 1,335 | $19.03 | $25.4K | 26,872 | SEC↗ |
| Sarma Purnanand D | President and CEO | P Buy | 2021-05-25 | 2021-05-26 | 10,500 | $18.41 | $193.3K | 10,500 | SEC↗ |
| RAPP MICHAEL | Director | P Buy | 2021-05-25 | 2021-05-26 | 19,303 | $18.32 | $353.6K | 134,530 | SEC↗ |
| Lefenfeld Michael | Director | P Buy | 2021-05-25 | 2021-05-26 | 2,715 | $18.44 | $50.1K | 25,537 | SEC↗ |
| LAMATTINA JOHN L | Director | P Buy | 2021-05-24 | 2021-05-26 | 338 | $18.44 | $6.2K | 46,726 | SEC↗ |
| LAMATTINA JOHN L | Director | P Buy | 2021-05-24 | 2021-05-26 | 5,102 | $18.58 | $94.8K | 51,828 | SEC↗ |
| WAGENHEIM PHILIP | Director | P Buy | 2021-05-24 | 2021-05-26 | 13,500 | $18.35 | $247.7K | 397,397 | SEC↗ |
| RAPP MICHAEL | Director | P Buy | 2021-05-24 | 2021-05-26 | 31,895 | $18.38 | $586.2K | 115,227 | SEC↗ |
| Lefenfeld Michael | Director | P Buy | 2021-05-24 | 2021-05-26 | 600 | $17.80 | $10.7K | 22,822 | SEC↗ |
| Roche Corleen M. | Chief Financial Officer | A Award deriv | 2021-04-19 | 2021-04-21 | 125,000 | — | $0 | 125,000 | SEC↗ |
| Giesing Dennis H | Chief Development Officer | A Award deriv | 2021-03-25 | 2021-03-29 | 125,000 | — | $0 | 125,000 | SEC↗ |
| RAPP MICHAEL | Director, 10% Owner | A Award deriv | 2020-11-03 | 2020-11-05 | 7,500 | — | $0 | 7,500 | SEC↗ |
| BARON RICHARD A | Director | A Award deriv | 2020-11-03 | 2020-11-05 | 7,500 | — | $0 | 7,500 | SEC↗ |
| LAMATTINA JOHN L | Director | A Award deriv | 2020-11-03 | 2020-11-05 | 7,500 | — | $0 | 7,500 | SEC↗ |
| Lefenfeld Michael | Director | A Award deriv | 2020-11-03 | 2020-11-05 | 7,500 | — | $0 | 7,500 | SEC↗ |
| WAGENHEIM PHILIP | Director | A Award deriv | 2020-11-03 | 2020-11-05 | 7,500 | — | $0 | 7,500 | SEC↗ |
| Widlitz Michael | Director | A Award deriv | 2020-11-03 | 2020-11-05 | 7,500 | — | $0 | 7,500 | SEC↗ |
| Stoneman Sandra G. | Chief Legal Officer & Gen Co | A Award deriv | 2020-11-03 | 2020-11-05 | 148,837 | — | $0 | 148,837 | SEC↗ |
| LAMATTINA JOHN L | Director | C Conversion deriv | 2020-10-06 | 2020-10-08 | 46,388 | — | $0 | 0 | SEC↗ |
| LAMATTINA JOHN L | Director | C Conversion deriv | 2020-10-06 | 2020-10-08 | 11,111 | — | $0 | 0 | SEC↗ |
| LAMATTINA JOHN L | Director | C Conversion deriv | 2020-10-06 | 2020-10-08 | 11,111 | — | $0 | 11,111 | SEC↗ |
| Lefenfeld Michael | Director | C Conversion deriv | 2020-10-06 | 2020-10-08 | 11,111 | — | $0 | 0 | SEC↗ |
| Lefenfeld Michael | Director | C Conversion deriv | 2020-10-06 | 2020-10-08 | 22,222 | — | $0 | 0 | SEC↗ |
| Lefenfeld Michael | Director | C Conversion deriv | 2020-10-06 | 2020-10-08 | 11,111 | — | $0 | 11,111 | SEC↗ |
| MORRIS I WISTAR III | 10% Owner | C Conversion deriv | 2020-10-06 | 2020-10-08 | 111,111 | — | $0 | 111,111 | SEC↗ |
| MORRIS I WISTAR III | 10% Owner | C Conversion deriv | 2020-10-06 | 2020-10-08 | 111,111 | — | $0 | 0 | SEC↗ |
| MORRIS I WISTAR III | 10% Owner | C Conversion deriv | 2020-10-06 | 2020-10-08 | 882,475 | — | $0 | 0 | SEC↗ |
| MORRIS I WISTAR III | 10% Owner | C Conversion deriv | 2020-10-06 | 2020-10-08 | 38,464 | — | $0 | 0 | SEC↗ |
| RAPP MICHAEL | Director | C Conversion deriv | 2020-10-06 | 2020-10-08 | 555,554 | — | $0 | 0 | SEC↗ |
| RAPP MICHAEL | Director | C Conversion deriv | 2020-10-06 | 2020-10-08 | 166,666 | — | $0 | 166,666 | SEC↗ |
| RAPP MICHAEL | Director | C Conversion deriv | 2020-10-06 | 2020-10-08 | 166,666 | — | $0 | 0 | SEC↗ |
| Widlitz Michael | Director | C Conversion deriv | 2020-10-06 | 2020-10-08 | 51,315 | — | $0 | 0 | SEC↗ |
| LAMATTINA JOHN L | Director | C Conversion | 2020-10-06 | 2020-10-08 | 46,388 | — | $0 | 46,388 | SEC↗ |
| Lefenfeld Michael | Director | C Conversion | 2020-10-06 | 2020-10-08 | 22,222 | — | $0 | 22,222 | SEC↗ |
| MORRIS I WISTAR III | 10% Owner | C Conversion | 2020-10-06 | 2020-10-08 | 882,475 | — | $0 | 882,475 | SEC↗ |
| MORRIS I WISTAR III | 10% Owner | C Conversion | 2020-10-06 | 2020-10-08 | 38,464 | — | $0 | 38,464 | SEC↗ |
| RAPP MICHAEL | Director | C Conversion | 2020-10-06 | 2020-10-08 | 555,554 | — | $0 | 555,554 | SEC↗ |
| RAPP MICHAEL | Director | P Buy | 2020-10-06 | 2020-10-08 | 83,332 | $12.00 | $1000.0K | 638,886 | SEC↗ |
| Widlitz Michael | Director | C Conversion | 2020-10-06 | 2020-10-08 | 51,315 | — | $0 | 51,315 | SEC↗ |
| Fitzgerald Richard F | Chief Financial Officer | A Award deriv | 2020-10-01 | 2020-10-05 | 104,802 | — | $0 | 104,802 | SEC↗ |
| Fitzgerald Richard F | Chief Financial Officer | A Award deriv | 2020-10-01 | 2020-10-05 | 7,681 | — | $0 | 7,681 | SEC↗ |